IKZF1 in acute lymphoblastic leukemia: the rise before the fall?
Abstract Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and adolescents and in recent decades, the survival
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy
13:59
סגור לתגובות על High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy
Abstract Immunotherapy has emerged as an attractive option for patients with relapsed or refractory high-risk neuroblastoma (HRNB). Neuroblastoma (NB), a
Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
13:35
סגור לתגובות על Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents
13:25
סגור לתגובות על International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents
Abstract Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma
12:55
סגור לתגובות על Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma
Loredana Amoroso, MD et al., Cancer Research and Treatment : Official Journal of Korean Cancer Association 2018; 50(1): 148-155.
A modern approach to multiple pulmonary resections in children with recurrent metastatic pulmonary disease
14:40
סגור לתגובות על A modern approach to multiple pulmonary resections in children with recurrent metastatic pulmonary disease
Abstract Implications of repeated resections of pulmonary metastasis (PM) are not well documented in the modern era. Fifteen children underwent
Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
14:24
סגור לתגובות על Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
Franco Locatelli, Martin Schrappe, Maria Ester Bernardo and Sergio Rutella
Blood 2012 :blood-2012-02-265884
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board
14:02
סגור לתגובות על Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board
Nathalie Gaspar et al., Journal of Clinical Oncology 2015 33:27, 3036-3046
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
13:52
סגור לתגובות על Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
Loredana Amoroso, MD et al., Cancer Research and Treatment : Official Journal of Korean Cancer Association 2018; 50(1): 148-155.
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
13:46
סגור לתגובות על The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
Deepa Bhojwani, MD, Jun J. Yang, PhD, Ching-Hon Pui, MD, Pediatric clinics of North America, Vol: 62, Issue: 1,
